Clinical Trials
16
Active:0
Completed:4
Trial Phases
4 Phases
Phase 1:5
Phase 2:2
Phase 3:4
+1 more phases
Drug Approvals
76
PHILIPPINES:76
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
Not Applicable
5 (31.3%)Phase 1
5 (31.3%)Phase 3
4 (25.0%)Phase 2
2 (12.5%)A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2061
Not Applicable
Not yet recruiting
- Conditions
- Healthy Subjects
- Interventions
- Drug: SYH2061Drug: Placebo
- First Posted Date
- 2025-11-21
- Last Posted Date
- 2025-11-21
- Target Recruit Count
- 40
- Registration Number
- NCT07241910
A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2070 Injection
Not Applicable
Not yet recruiting
- Conditions
- Healthy Subjects (HS)
- Interventions
- Drug: SYH2070 injectionDrug: Placebo
- First Posted Date
- 2025-11-21
- Last Posted Date
- 2025-11-21
- Target Recruit Count
- 48
- Registration Number
- NCT07241923
Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound) in Breast Cancer Patients
Not Applicable
Recruiting
- Conditions
- Bioequivalence
- Interventions
- First Posted Date
- 2025-07-31
- Last Posted Date
- 2025-07-31
- Target Recruit Count
- 28
- Registration Number
- NCT07096869
- Locations
- 🇨🇳
The First Hospital of Jilin University, Changchun, Jilin, China
Study of SYH2062 Injection in Healthy Chinese Volunteers
Phase 1
Recruiting
- Conditions
- Healthy Chinese Volunteers
- Interventions
- Drug: SYH2062 injectionDrug: SYH2062-Matching placebo
- First Posted Date
- 2025-02-24
- Last Posted Date
- 2025-04-30
- Target Recruit Count
- 46
- Registration Number
- NCT06842537
- Locations
- 🇨🇳
Chinese Academy of Medical Science and Peking Union Medical College Hospital, Beijing, Beijing, China
Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting
Phase 3
Not yet recruiting
- Conditions
- Post-operative Nausea and Vomiting (PONV)
- Interventions
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-09
- Target Recruit Count
- 486
- Registration Number
- NCT06543966
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found